Group asks to evaluate nanotech ethics, safety risks

Group asks to evaluate nanotech ethics, safety risks

The development of products that use nanotechnology is racing ahead of the understanding of their potential health and safety risks, according to Patrick lin, research director of The Nanoethics Group, which is assembling industry and academic representatives worldwide to examine ethical and social issues raised by the technology.

"More and more nanotechnology products are being introduced into the marketplace, and there's enough questions surrounding nanotechnology where we should really pause and really think [about steps that may be needed to protect health and safety]", Lin said.

He called for studies, such as an environmental impact study before these products were rushed into the marketplace.

The group announced that it had created an advisory board of about 30 researchers from a variety of disciplines, including molecular manufacturing, medicine, law, bioethics and chemical engineering, to study the issues raised by nanotechnology development.

Nanotechnology involves the manipulation of material on an atomic scale, which allows scientists to develop incredibly small and strong materials and, in IT applications, components that theoretically could fit an enormous amount of computing power in extremely small devices.

But there are concerns. Nanotechnology was so new that the effect of inhaling or absorbing nanotech materials through a person's skin were unknown, Lin said.

In a report earlier this month, the Woodrow Wilson International Center for Scholars in Washington said new laws might be needed to manage the risks associated with nanotechnology, including a requirement that companies submit plans demonstrating that their products are safe.

The Nanoethics Group, a nonprofit organisation funded by its participants, sees itself as an advisory and educational group.

Among those on its board are: Nick Bostrom, director of the Future of Humanity Institute at Oxford University; C. Christopher Hook, assistant professor of medicine and a consultant in hematology and medical ethics at the Mayo Clinic College of Medicine; Ray Kurzweil, CEO of Kurzweil Technologies; and Tihamer Toth-Fejel, a research engineer at General Dynamics Advanced Information Systems. The full list of board members is available online at

Follow Us

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.
Show Comments